share_log

Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wilson Mark Andrew

Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wilson Mark Andrew

内克塔治疗 | 4:持股变动声明-高管 Wilson Mark Andrew
美股SEC公告 ·  08/21 09:18
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息